犬の左ブンドルブランクに埋め込まれた生物ペースメーカーは,生理学的に許容可能なペースで心室脱出リズムを提供する
Alexei N Plotnikov1, Eugene A Sosunov, Jihong Qu
1Center for Molecular Therapeutics, Department of Pharmacology, College of Physicians and Surgeons of Columbia University, New York, NY 10032, USA.
Circulation
|January 22, 2004
まとめ
左束の分岐系にあるHCN2遺伝子を用いた遺伝子療法は,犬に生物学的ペースメーカーを作り,生理学的に許容可能な心拍数を提供することに成功した. 長期的な有効性を確認するためにさらなる研究が必要である.
科学分野:
- 心血管科学の研究について
- 遺伝子療法の遺伝子治療法
- 電気生理学 電気生理学
背景:
- 左束の枝 (LBB) システムは,心臓の電気伝導の重要な構成要素です.
- 生物学的ペースメーカーの開発は,ブラジカルディアに対する新しい治療戦略を提供することができる.
- HCN2遺伝子は,心臓のペースメーカーに作用することが知られている.
研究 の 目的:
- LBBシステムへのHCN2遺伝子の投与が,ペースメーカー機能を誘発する可能性を調査する.
- この遺伝子療法のアプローチで生理学的心拍数を達成できるかどうかを判断する.
主な方法:
- HCN2とGFPを運ぶアデノウイルスベクターは,犬のLBBに注入されました.
- 対照群は,GFP単独または塩素で投与された.
- 動物はECGでモニタリングされ,心臓は遺伝子発現と電気生理学的特性について死後に分析されました.
主要な成果:
- 注射後,一時的な心室動脈不律が観察され,その後シヌスリズムが確立されました.
- HCN2で治療された犬は,対照群と比較して,管刺激中により速い心室脱出リズムを示した.
- エクスビヴォ分析では,治療を受けた動物のLBBにおける自動性の増加とHCN2過剰発現が確認されました.
結論:
- HCN2でLBBシステムを標的とする遺伝子治療は,生物学的ペースメーカーの活動を許容可能な速さで誘導することができます.
- このアプローチは,心室の脱出リズムを作り出すのに有望であることが示されています.
- 長期的な安定性と実現可能性については,さらなる調査が必要である.
関連する概念動画
Electrophysiology of Normal Cardiac Rhythm
7.8K
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
7.8K
Mechanism of Cardiac Arrhythmias
2.7K
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.7K
Conduction System of the Heart
13.5K
Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
13.5K
Disturbances in Heart Rhythm
5.3K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
5.3K
Dysrhythmias IV: Characteristics of Bradyarrhythmias
788
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
788
Dysrhythmias VI: Management of Dysrhythmias
597
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
597


